MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/87.5/0.1/21.03.25 Share Price

Warrant

DE000MG4D229

Market Closed - Börse Stuttgart 19:56:49 08/07/2024 BST
0.42 EUR -12.50% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/87.5/0.1/21.03.25
Current month-8.70%
1 month-61.11%
Date Price Change
08/07/24 0.42 -12.50%
05/07/24 0.48 0.00%
03/07/24 0.48 +4.35%
02/07/24 0.46 -9.80%
01/07/24 0.51 +10.87%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 07:56 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D22
ISINDE000MG4D229
Date issued 16/05/2024
Strike 87.5 $
Maturity 21/03/2025 (256 Days)
Parity 10 : 1
Emission price 2.5
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.45
Lowest since issue 0.42
Delta0.31x
Omega 3.732
Premium64.48x
Gearing11.91x
Moneyness 0.6407
Difference Strike 31.44 $
Difference Strike %+35.93%
Spread 0.03
Spread %6.67%
Theoretical value 0.4350
Implied Volatility 64.30 %
Total Loss Probability 84.72 %
Intrinsic value 0.000000
Present value 0.4350
Break even 92.21 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
56.06 USD
Average target price
83.43 USD
Spread / Average Target
+48.82%
Consensus